16:21 EDT Zentalis (ZNTL) files $250M mixed securities shelf
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ZNTL:
- Zentalis Highlights Promising Azenosertib Data at SGO 2025
- Positive Buy Rating for Zentalis Pharmaceuticals Driven by Promising Efficacy and Safety of Azenosertib in PROC Treatment
- Zentalis presents updated clinical data on azenosertib as SGO 2025
- ZNTL Upcoming Earnings Report: What to Expect?
- Zentalis price target lowered to $6 from $8 at Guggenheim